These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2839089)

  • 1. VIP1-12 is a ligand for the CD4/human immunodeficiency virus receptor.
    Sacerdote P; Ruff MR; Pert CB
    Ann N Y Acad Sci; 1988; 527():574-8. PubMed ID: 2839089
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV infection: the cellular picture.
    Weber JN; Weiss RA
    Sci Am; 1988 Oct; 259(4):100-9. PubMed ID: 2854299
    [No Abstract]   [Full Text] [Related]  

  • 3. The CD4 receptor for the AIDS virus.
    Weiss RA; Clapham PR; McClure M; Marsh M
    Biochem Soc Trans; 1989 Aug; 17(4):644-7. PubMed ID: 2475372
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of the residues in human CD4 critical for the binding of HIV.
    Arthos J; Deen KC; Chaikin MA; Fornwald JA; Sathe G; Sattentau QJ; Clapham PR; Weiss RA; McDougal JS; Pietropaolo C
    Cell; 1989 May; 57(3):469-81. PubMed ID: 2541915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus.
    Berger EA; Fuerst TR; Moss B
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2357-61. PubMed ID: 2451247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the CD4 antigen in HIV infection and immune pathogenesis.
    Sattentau QJ
    AIDS; 1988; 2 Suppl 1():S11-6. PubMed ID: 2852500
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV infection is blocked in vitro by recombinant soluble CD4.
    Fisher RA; Bertonis JM; Meier W; Johnson VA; Costopoulos DS; Liu T; Tizard R; Walker BD; Hirsch MS; Schooley RT
    Nature; 1988 Jan; 331(6151):76-8. PubMed ID: 2829022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.
    Weinhold KJ; Lyerly HK; Stanley SD; Austin AA; Matthews TJ; Bolognesi DP
    J Immunol; 1989 May; 142(9):3091-7. PubMed ID: 2468713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid solution immunoassay to quantify binding of the human immunodeficiency virus envelope glycoprotein to soluble CD4.
    McQuade TJ; Pitts TW; Tarpley WG
    Biochem Biophys Res Commun; 1989 Aug; 163(1):172-6. PubMed ID: 2549987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1.
    Kowalski M; Ardman B; Basiripour L; Lu YC; Blohm D; Haseltine W; Sodroski J
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3346-50. PubMed ID: 2541442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MHC-binding and gp120-binding functions of CD4 are separable.
    Lamarre D; Ashkenazi A; Fleury S; Smith DH; Sekaly RP; Capon DJ
    Science; 1989 Aug; 245(4919):743-6. PubMed ID: 2549633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor.
    Nygren A; Bergman T; Matthews T; Jörnvall H; Wigzell H
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6543-6. PubMed ID: 2842778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD4 antigen: physiological ligand and HIV receptor.
    Sattentau QJ; Weiss RA
    Cell; 1988 Mar; 52(5):631-3. PubMed ID: 2830988
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
    Fenouillet E; Clerget-Raslain B; Gluckman JC; Guétard D; Montagnier L; Bahraoui E
    J Exp Med; 1989 Mar; 169(3):807-22. PubMed ID: 2538547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization.
    Ho DD; Kaplan JC; Rackauskas IE; Gurney ME
    Science; 1988 Feb; 239(4843):1021-3. PubMed ID: 2830667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A strong homology exists between the active T-cell binding gp120 octapeptide of human immunodeficiency virus and the subtilisin cleavage peptide of bovine ribonuclease A.
    Pincus MR; Carty RP; Chen J; Murphy RB
    Biochem Biophys Res Commun; 1987 Feb; 143(1):248-51. PubMed ID: 3030317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses.
    Chirmule N; Kalyanaraman V; Oyaizu N; Pahwa S
    J Acquir Immune Defic Syndr (1988); 1988; 1(5):425-30. PubMed ID: 2851650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
    Traunecker A; Lüke W; Karjalainen K
    Nature; 1988 Jan; 331(6151):84-6. PubMed ID: 2829024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor molecule blocks HIV.
    Weiss RA
    Nature; 1988 Jan; 331(6151):15. PubMed ID: 2829021
    [No Abstract]   [Full Text] [Related]  

  • 20. Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.
    Lyerly HK; Matthews TJ; Langlois AJ; Bolognesi DP; Weinhold KJ
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4601-5. PubMed ID: 3037522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.